-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Reporter | Zheng Jie
Edit | Xie Xin
The change of shareholders and executives of the well-known pharmaceutical O2O Dingdang Kuaiyao has aroused public attention
.
The Tianyancha APP shows that Dingdang Kuaiyao Technology Group Co.
, Ltd.
, the main operator of Dingdang Kuaiyao, has recently undergone several industrial and commercial changes.
Yang Wenlong, Yu Lei and other 11 directors, supervisors and senior executives have resigned, including Taikang Life Insurance Co.
, Ltd.
and Beijing Zhongguancun Longmen Fund Investment 18 original shareholders, including the Center and Qiling Equity Investment Center of Ningbo Meishan Free Trade Port Zone, withdrew
.
In addition, the current registered capital of 52,941,200 yuan has also dropped by nearly half from 99,476,815 on December 31, 2020.
Property management and office rentals have been added to the scope of business
.
According to Tianyancha APP, there are currently 5 shareholders of Dingdang Kuaiyao Technology Group Co.
, Ltd.
, according to their shareholding ratios: Zhuhai Dingdang No.
4 Investment Center, Yang Wenlong, Zhuhai Dingdang No.
3 Enterprise Management Consulting Center, and Zhuhai Dingdang No.
1 Enterprise Management Consulting Center, Zhuhai Dingdang No.
2 Enterprise Management Consulting Center
.
The main personnel of the company are shown as: Xu Ning, Meng Fanzhou, and Yang Yibin
It is worth noting that among the shareholders who withdrew this time, Taikang Life Insurance Co.
, Ltd.
, Beijing Zhongguancun Longmen Fund Investment Center, Ningbo Meishan Free Trade Port Area Qilai Equity Investment Center and other shareholders were new shareholders on December 31, 2020.
Less than half a year ago
.
Dingdang Kuaiyao was established in 2014.
At that time, pharmaceutical e-commerce was booming.
Projects such as Dingdang Kuaiyao, Kuaifang Drug Delivery, Yaoqili, and Yaokuaihao successively received financing, and built an online platform to connect pharmacies and users.
The main focus was 1 Hourly delivery of medicines
.
Public reports show that Dingdang Kuaiyao completed the B+ round of financing in October 2020, with a financing amount of 1 billion yuan.
Taikang Life, Haier Medical, Longmen Investment and CMB International CMB Telecom Fund, Sinopharm Zhongjin, SoftBank China and other old shareholders jointly For investment, China Renaissance Capital acts as the exclusive financial advisor
.
The 18 shareholders collectively withdrew and the registered capital was halved.
Suddenly, industry speculations abound
.
On May 27, the interface news reporter called Dingdang Kuaiyao's industrial and commercial registration number, and the other party said that he did not know the matter
Therefore, there is a speculation that Dingdang Kuaiyao may undergo a major adjustment in its organizational structure due to its search for listing.
Dingdang Kuaiyao has indeed been favored by capital to survive from a high-input low-return pharmaceutical e-commerce company
.
Another argument is that Dingdang Kuaiyao may have problems with substandard performance and tight cash flow
.
According to Caijing, shareholders collectively withdrew during the same period, possibly because the company's performance did not meet the expectations at the time of investment
However, the above are only speculations made by industry analysts based on changes in Dingdang Kuaiyao's industrial and commercial information
.
In October 2020, when Dingdang Pharmaceutical’s B+ round of financing, Yang Wenlong, the founder and chairman of Dingdang Kuaiyao, also proposed that the financing is mainly used to accelerate its "Thousands of Cities and Ten Thousands of Stores" project.
O2O, a pharmaceutical O2O that focuses on fast delivery of medicines, has also been very popular with capital
.
At the end of November 2014, Yaogeli received millions of yuan in angel round financing; in 2015, Kuaifang Medicine received a total of 250 million yuan in round A and B rounds, and in April 2017, it received 60 million yuan from Buchang Pharmaceuticals.
However, only Dingdang Kuaiyao is still active today, which may be related to the old pharmaceutical company Renhe Group behind its founder Yang Wenlong
.
At the end of the 1990s, Yang Wenlong, who was born as a buyer of Chinese herbal medicines, established Renhe Group.
However, due to problems such as low coordination among offline pharmacies, Dingdang Kuaiyao began to build its own offline pharmacies and logistics distribution team since 2016.
In June 2017, Dingdang Kuaiyao was established in Beijing, Shanghai, Guangzhou, Shenzhen, and Chengdu.
, Zhengzhou has more than 200 stores in seven cities
.
In November 2018, Dingdang Kuaiyao launched the "Hundred Cities, Thousands of Stores" strategy, planning to open 2,000 offline pharmacies in 300 cities in three years
At present, the pharmaceutical e-commerce field has all established king flags, Internet medical services represented by WeDoctor, Ping An Health, Dingxiang Doctor, Chunyu Doctor, etc.
Insufficient prescription rights and difficulty in being included in medical insurance are the pain points of the entire Internet medical treatment.
